• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-6(IL-6)-JAK-STAT与糖皮质激素-核受体途径之间的串扰:IL-6和糖皮质激素对IL-6反应元件的协同激活。

Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid.

作者信息

Takeda T, Kurachi H, Yamamoto T, Nishio Y, Nakatsuji Y, Morishige K i, Miyake A, Murata Y

机构信息

Department of Obstetrics and Gynecology, Osaka University Medical School, Osaka 565-0871, Japan.

出版信息

J Endocrinol. 1998 Nov;159(2):323-30. doi: 10.1677/joe.0.1590323.

DOI:10.1677/joe.0.1590323
PMID:9795374
Abstract

Cytokines and steroid hormones use different sets of signal transduction pathways, which seem to be unrelated. Interleukin-6 (IL-6) uses JAK tyrosine kinase and STAT (signal transducer and activator of transcription) transcription factor. Glucocorticoid binds glucocorticoid receptor (GR), which is a member of the steroid receptor superfamily. We have studied the crosstalk between the IL-6-JAK-STAT and glucocorticoid-nuclear receptor pathways. IL-6 and glucocorticoid synergistically activated the IL-6 response element on the rat alpha2-macroglobulin promoter (APRE)-driven luciferase gene. The exogenous expression of GR enhanced the synergism. The exogenous expression of dominant negative STAT3 completely abolished the IL-6 plus glucocorticoid-induced activation of the APRE-luciferase gene. Tyrosine phosphorylation of STAT3 stimulated by IL-6 alone was not different from that by IL-6 plus glucocorticoid. The protein level of STAT3 was also not increased by glucocorticoid stimulation. The time course of STAT3 tyrosine phosphorylation by IL-6 plus glucocorticoid was not different from that by IL-6 alone. The synergism was studied on the two other IL-6 response elements, the junB promoter (JRE-IL-6) and the interferon regulatory factor-1 (IRF-1) promoter (IRF-GAS) which could be activated by STAT3. The synergistic activation by glucocorticoid on the IL-6-activated JRE-IL-6 and the IRF-GAS-driven luciferase gene was not detected. Glucocorticoid did not change the mobility of IL-6-induced APRE-binding proteins in a gel shift assay. These results suggest that the synergism was through the GR and STAT3, and the coactivation pathway which was specific for APRE was the target of glucocorticoid.

摘要

细胞因子和类固醇激素使用不同的信号转导途径组,这些途径似乎并无关联。白细胞介素-6(IL-6)使用JAK酪氨酸激酶和STAT(信号转导子和转录激活子)转录因子。糖皮质激素与糖皮质激素受体(GR)结合,GR是类固醇受体超家族的成员。我们研究了IL-6-JAK-STAT和糖皮质激素-核受体途径之间的相互作用。IL-6和糖皮质激素协同激活大鼠α2-巨球蛋白启动子(APRE)驱动的荧光素酶基因上的IL-6反应元件。GR的外源性表达增强了协同作用。显性负性STAT3的外源性表达完全消除了IL-6加糖皮质激素诱导的APRE-荧光素酶基因的激活。单独由IL-6刺激引起的STAT3酪氨酸磷酸化与由IL-6加糖皮质激素引起的并无差异。糖皮质激素刺激也未使STAT3的蛋白水平升高。IL-6加糖皮质激素引起的STAT3酪氨酸磷酸化的时间进程与单独由IL-6引起的并无差异。在另外两个可被STAT3激活的IL-6反应元件,即junB启动子(JRE-IL-6)和干扰素调节因子-1(IRF-1)启动子(IRF-GAS)上研究了协同作用。未检测到糖皮质激素对IL-6激活的JRE-IL-6和IRF-GAS驱动的荧光素酶基因的协同激活作用。在凝胶迁移试验中,糖皮质激素未改变IL-6诱导的APRE结合蛋白的迁移率。这些结果表明,协同作用是通过GR和STAT3实现的,且对APRE具有特异性的共激活途径是糖皮质激素的作用靶点。

相似文献

1
Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid.白细胞介素-6(IL-6)-JAK-STAT与糖皮质激素-核受体途径之间的串扰:IL-6和糖皮质激素对IL-6反应元件的协同激活。
J Endocrinol. 1998 Nov;159(2):323-30. doi: 10.1677/joe.0.1590323.
2
Stimulation of endogenous GH and interleukin-6 receptors selectively activates different Jaks and Stats, with a Stat5 specific synergistic effect of dexamethasone.内源性生长激素和白细胞介素-6受体的刺激选择性地激活不同的Janus激酶(Jaks)和信号转导及转录激活因子(Stats),地塞米松具有Stat5特异性协同效应。
J Endocrinol. 2000 May;165(2):301-11. doi: 10.1677/joe.0.1650301.
3
Alternative signaling mechanism of leukemia inhibitory factor responsiveness in a differentiating embryonal carcinoma cell.
Endocrinology. 1997 Jul;138(7):2689-96. doi: 10.1210/endo.138.7.5280.
4
Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.白细胞介素-2通过一种涉及信号转导及转录激活因子5(STAT5)而非激活蛋白-1(AP-1)的机制抑制糖皮质激素受体的转录活性。
Mol Endocrinol. 2001 Jul;15(7):1062-76. doi: 10.1210/mend.15.7.0657.
5
IL-6-inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like site binding protein(s).JunB启动子的白细胞介素-6反应元件上的白细胞介素-6诱导复合物包含信号转导和转录激活因子3(Stat3)以及36 kDa CRE样位点结合蛋白。
Oncogene. 1996 Feb 1;12(3):547-54.
6
Interferon-gamma induces AT(2) receptor expression in fibroblasts by Jak/STAT pathway and interferon regulatory factor-1.γ干扰素通过Jak/STAT信号通路和干扰素调节因子-1诱导成纤维细胞中AT(2)受体的表达。
Circ Res. 2000 Feb 4;86(2):233-40. doi: 10.1161/01.res.86.2.233.
7
The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.JAK抑制剂JAB/SOCS-1可选择性抑制细胞因子诱导的JAK-STAT激活,但对v-Src诱导的JAK-STAT激活无抑制作用。
Oncogene. 2000 Sep 28;19(41):4795-801. doi: 10.1038/sj.onc.1203829.
8
Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.通过白细胞介素-6信号转导受体蛋白gp130激活蛋白酪氨酸磷酸酶SHP2需要酪氨酸激酶Jak1,并限制急性期蛋白的表达。
Biochem J. 1998 Nov 1;335 ( Pt 3)(Pt 3):557-65. doi: 10.1042/bj3350557.
9
Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.白细胞介素-2、白细胞介素-12和干扰素-α刺激人自然杀伤细胞过程中Janus激酶-信号转导子和转录激活子信号通路的差异利用
J Immunol. 1996 Jul 1;157(1):126-37.
10
Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.白细胞介素6抑制增殖,并与表皮生长因子受体自分泌环协同作用,增加T47D乳腺癌细胞的迁移。
Cancer Res. 2001 Jan 1;61(1):383-91.

引用本文的文献

1
Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies.导致淋巴系统恶性肿瘤中糖皮质激素抵抗的分子机制。
Cancer Drug Resist. 2019 Sep 19;2(3):647-664. doi: 10.20517/cdr.2019.29. eCollection 2019.
2
Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?地塞米松治疗严重 COVID-19:在细胞和分子水平上的作用机制是什么?
Int J Mol Sci. 2021 Jun 23;22(13):6764. doi: 10.3390/ijms22136764.
3
Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents.
受杜氏肌营养不良症影响的骨骼肌中的抗炎和一般糖皮质激素生理学:探索甾体节约剂。
Int J Mol Sci. 2020 Jun 28;21(13):4596. doi: 10.3390/ijms21134596.
4
Combination of cationic dexamethasone derivative and STAT3 inhibitor (WP1066) for aggressive melanoma: a strategy for repurposing a phase I clinical trial drug.阳离子地塞米松衍生物与 STAT3 抑制剂(WP1066)联合用于侵袭性黑色素瘤:一种重新利用 I 期临床试验药物的策略。
Mol Cell Biochem. 2017 Dec;436(1-2):119-136. doi: 10.1007/s11010-017-3084-z. Epub 2017 Jun 5.
5
MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.MUC16通过抑制p53调控TSPYL5以促进肺癌细胞生长和化疗耐药。
Clin Cancer Res. 2017 Jul 15;23(14):3906-3917. doi: 10.1158/1078-0432.CCR-16-2530. Epub 2017 Feb 14.
6
Deciphering the regulatory logic of an ancient, ultraconserved nuclear receptor enhancer module.解读一个古老的、超保守的核受体增强子模块的调控逻辑。
Mol Endocrinol. 2015 Jun;29(6):856-72. doi: 10.1210/me.2014-1349. Epub 2015 Apr 13.
7
RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.RhoC通过过度表达IL-6和STAT3磷酸化来调控头颈部鳞状细胞癌中的癌症干细胞。
PLoS One. 2014 Feb 12;9(2):e88527. doi: 10.1371/journal.pone.0088527. eCollection 2014.
8
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.STAT3 信号通路的激活与接受 R-CHOP 治疗的弥漫性大 B 细胞淋巴瘤患者的不良预后相关。
J Clin Oncol. 2013 Dec 20;31(36):4520-8. doi: 10.1200/JCO.2012.45.6004. Epub 2013 Nov 12.
9
Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism.应激激素促进 B16-F10 黑色素瘤转移的生长:一种依赖于白细胞介素 6 和谷胱甘肽的机制。
J Transl Med. 2013 Mar 22;11:72. doi: 10.1186/1479-5876-11-72.
10
The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.可溶性受体调节白介素 6 转导信号的平衡可预测绝经后类风湿关节炎患者的 RANKL/骨保护素比值。
Rheumatol Int. 2012 Jan;32(1):199-206. doi: 10.1007/s00296-010-1606-z. Epub 2010 Sep 7.